Synopsis of recent research by authors named "Abdallah Khan"
Abdallah Khan's recent research spans multiple domains including critical care, surgical outcomes, and the analysis of biomedical interventions, reflecting a commitment to enhancing patient care in complex medical scenarios.
His studies include an exploration of cerebral autoregulation during ECMO therapy, the implications of COVID-19 on bariatric surgery outcomes, and the efficacy of gilteritinib in treating relapsed FLT3-mutant AML patients, showcasing his involvement in innovative treatment approaches.
Additionally, Khan investigates the safety of new surgical techniques in the Middle East, while also delving into the biochemical properties of medicinal plants, demonstrating a multidisciplinary approach to understanding health-related issues.
